Pharmacological studies revealed that Chinese medicine (CM) could be applied to treat COPD by regulating various signaling pathways such as JAK2/STAT3, PI3K/Akt/NF-kappaB and EGFR-PI3K-AKT signal pathways, et, al. [12–18]. This evidence concerns the gene AKT1 and chronic obstructive pulmonary disease.